Ocular Hypertension
Quark Pharmaceutical's QPI-1007 Exhibits Neuroprotective Effects in Glaucoma Model
Published in Gene Therapy Weekly, July 15th, 2010
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, announced results from a second study of QPI-1007, a neuroprotective siRNA drug, in rat ocular hypertension model of glaucoma, conducted by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal. Prof. Di Polo's recent study in a rat model of glaucoma shows that QPI-1007, when given in two intravitreal injections after induction of ocular hypertension (at two weeks and 10 days later), can deliver a sustained neuroprotective effect, as measured by a significant attenuation in RGC death five weeks after disease induction. Ocular neuroprotection,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2010-07-15)
More Articles from Gene Therapy Weekly
- Biotechnology
Data from University of Seville, Department of Organic Chemistry provide new insights into biotechnology - Drug Development
Data on drug development reported by researchers at Innsbruck Medical University - Effector Caspases
Data on effector caspases described by researchers at Chongqing Medical University - Cystic Fibrosis
Findings from University of Virginia provide new insights into cystic fibrosis - Nasopharyngeal Carcinoma
Investigators at Hong Kong Baptist University, Department of Biology release new data on nasopharyngeal carcinoma - MADS Domain Proteins
New MADS domain proteins study findings reported from R. Farra and co-authors - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
